Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TeleMed United appears to be a healthcare services and digital health company focused on telemedicine deployment rather than drug development. Publicly available references indicate the company has been involved in deploying telemedicine pilots and technology-enabled clinics in underserved regions of Africa, with an emphasis on improving healthcare access. The company was identified in 2020 conference materials in connection with telemedicine strategy and implementation, and its chief executive was named as Krystylle Richardson. There is no evidence that TeleMed United is a biotech or pharmaceutical developer, and no drug pipeline, therapeutic targets, or clinical-stage assets were identified in available sources. The company is best characterized as a telehealth and care-delivery organization operating in the healthcare technology/services segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TeleMed United.